Filing Flows › Comparisons › CNTB vs ISCO
Connect Biopharma Holdings vs International Stem Cell: CNTB and ISCO compared
Connect Biopharma Holdings is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $2.7M for International Stem Cell (Q2 2026). Connect Biopharma Holdings is growing faster (58× against +9% a year earlier). International Stem Cell is more profitable, with an operating margin of -1.3% against -636.0%.
Where the money goes: CNTB and ISCO
Connect Biopharma Holdings (CNTB) · Q2 2026
Connect Biopharma Holdings, Q2 2026: revenue $2.8M (58× year over year), operating margin -636.0%, net loss $17.3M, operating cash flow −$15.9M. The chart follows the revenue to costs, profit and cash.
International Stem Cell (ISCO) · Q2 2026
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
| Connect Biopharma Holdings (CNTB) | International Stem Cell (ISCO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $2.8M | $2.7M |
| Revenue growth, Y/Y | 58× | +9% |
| Operating margin | -636.0% | -1.3% |
| Net earnings | −$17.3M | −$71K |
| Net margin | -624.4% | -2.7% |
| Operating cash flow | −$15.9M | $167K |
| Free cash flow | — | $160K |
Where the revenue comes from
International Stem Cell
- Biomedical Market: $2.5M (94%)
- Anti Aging Skincare Market: $151K (6%)
Questions
Which is bigger, Connect Biopharma Holdings or International Stem Cell?
Connect Biopharma Holdings is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $2.7M for International Stem Cell (Q2 2026).
Is Connect Biopharma Holdings or International Stem Cell growing faster?
Connect Biopharma Holdings is growing faster (58× against +9% a year earlier).
Which is more profitable, Connect Biopharma Holdings or International Stem Cell?
International Stem Cell is more profitable, with an operating margin of -1.3% against -636.0%.
More: Connect Biopharma Holdings earnings · how Connect Biopharma Holdings makes money · International Stem Cell earnings · how International Stem Cell makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.